Cystic Fibrosis Pulmonary Guidelines
Top Cited Papers
- 1 November 2009
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 180 (9), 802-808
- https://doi.org/10.1164/rccm.200812-1845pp
Abstract
The natural history of cystic fibrosis lung disease is one of chronic progression with intermittent episodes of acute worsening of symptoms frequently called acute pulmonary exacerbations These exacerbations typically warrant medical intervention. It is important that appropriate therapies are recommended on the basis of available evidence of efficacy and safety. The Cystic Fibrosis Foundation therefore established a committee to define the key questions related to pulmonary exacerbations, review the clinical evidence using an evidence-based methodology, and provide recommendations to clinicians. It is hoped that these guidelines will be helpful to clinicians in the treatment of individuals with cystic fibrosis.This publication has 62 references indexed in Scilit:
- Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patientsJournal of Antimicrobial Chemotherapy, 2007
- Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesisThorax, 2007
- Pharmacokinetic and Pharmacodynamic Issues in the Treatment of Bacterial Infectious DiseasesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Comparison of a β-lactam alone versus β-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosisThe Journal of Pediatrics, 1999
- Controlled trial of aztreonam vs. tobramycin and azlocillin for acute pulmonary exacerbations of cystic fibrosisThe Pediatric Infectious Disease Journal, 1988
- Ceftazidime monotherapy vs. combined therapy in Pseudomonas pulmonary infections in cystic fibrosisThe Pediatric Infectious Disease Journal, 1987
- Comparison of cefoperazone sodium vs methicillin, ticarcillin, and tobramycin in treatment of pulmonary exacerbations in patients with cystic fibrosisThe Journal of Pediatrics, 1985
- A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosisThe Journal of Pediatrics, 1981
- Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?The Journal of Pediatrics, 1980
- Treatment of pulmonary infections in patients with cystic fibrosis: A comparative study of ticarcillin and gentamicinThe Journal of Pediatrics, 1977